| |
|
|
| Name: |
Vestal Point Capital LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10012 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
29 |
|
View All Holdings |
Currently
Viewing:
New Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
BGNE |
Beigene Ltd |
8 |
New |
$152.71 |
$50,827,000 |
325,000 |
4.2% |
50,827,000 |
325,000 |
0.359 |
N/A |
|
|
NARI |
Inari Medical, Inc. |
9 |
New |
$0.00 |
$38,384,000 |
800,000 |
3.17% |
38,384,000 |
800,000 |
1.549 |
N/A |
|
|
ARGX |
Argenx Se |
16 |
New |
$367.07 |
$19,686,000 |
50,000 |
1.63% |
19,686,000 |
50,000 |
0.106 |
N/A |
|
|
TGTX |
TG Therapeutics Inc |
18 |
New |
$16.71 |
$15,971,000 |
1,050,000 |
1.32% |
15,971,000 |
1,050,000 |
0.814 |
Drug Manufacturers - ... |
|
|
ATXS |
Astria Therapeutics, Inc |
19 |
New |
$9.02 |
$15,483,000 |
1,100,000 |
1.28% |
15,483,000 |
1,100,000 |
2.012 |
N/A |
|
|
BMRN |
Biomarin Pharmaceutical Inc |
20 |
New |
$88.63 |
$15,285,000 |
175,000 |
1.26% |
15,285,000 |
175,000 |
0.093 |
Drug Manufacturers - ... |
|
|
ALPN |
Alpine Immune Sciences Inc |
21 |
New |
$64.97 |
$13,874,000 |
350,000 |
1.15% |
13,874,000 |
350,000 |
0.534 |
N/A |
|
|
APLS |
Apellis Pharmaceuticals Inc |
24 |
New |
$40.61 |
$13,226,000 |
225,000 |
1.09% |
13,226,000 |
225,000 |
0.197 |
N/A |
|
|
SRPT |
Sarepta Therapeutics Inc |
25 |
New |
$123.46 |
$12,946,000 |
100,000 |
1.07% |
12,946,000 |
100,000 |
0.119 |
Drug Manufacturers - ... |
|
|
PRAX |
Praxis Precision Medicines,... |
26 |
New |
$0.00 |
$12,814,000 |
210,000 |
1.06% |
12,814,000 |
210,000 |
0.401 |
N/A |
|
|
INCY |
Incyte Corp |
28 |
New |
$57.31 |
$11,394,000 |
200,000 |
0.94% |
11,394,000 |
200,000 |
0.091 |
Biotechnology |
|
|
MGNX |
Macrogenics Inc |
29 |
New |
$4.55 |
$10,672,000 |
725,000 |
0.88% |
10,672,000 |
725,000 |
1.169 |
Biotechnology |
|
|
AGIO |
Agios Pharmaceuticals Inc |
30 |
New |
$31.50 |
$9,503,000 |
325,000 |
0.79% |
9,503,000 |
325,000 |
0.47 |
N/A |
|
|
SWAV |
Shockwave Medical, Inc. |
31 |
New |
$334.15 |
$8,141,000 |
25,000 |
0.67% |
8,141,000 |
25,000 |
0.068 |
N/A |
|
|
KRYS |
Krystal Biotech Inc |
32 |
New |
$162.83 |
$8,007,000 |
45,000 |
0.66% |
8,007,000 |
45,000 |
0.181 |
N/A |
|
|
KALV |
Kalvista Pharmaceuticals Inc |
33 |
New |
$11.30 |
$7,768,000 |
655,000 |
0.64% |
7,768,000 |
655,000 |
1.723 |
N/A |
|
|
GERN |
Geron Corporation |
34 |
New |
$3.48 |
$7,260,000 |
2,200,000 |
0.6% |
7,260,000 |
2,200,000 |
0.405 |
Drug Manufacturers - ... |
|
|
EXAS |
Exact Sciences Corp |
36 |
New |
$49.84 |
$6,906,000 |
100,000 |
0.57% |
6,906,000 |
100,000 |
0.056 |
Biotechnology |
|
|
VKTX |
Viking Therapeutics, Inc. |
38 |
New |
$62.75 |
$6,150,000 |
75,000 |
0.51% |
6,150,000 |
75,000 |
0.075 |
N/A |
|
|
PASG |
Passage Bio, Inc. |
39 |
New |
$1.13 |
$6,075,000 |
4,500,000 |
0.5% |
6,075,000 |
4,500,000 |
9.884 |
N/A |
|
|
ALLO |
Allogene Therapeutics, Inc. |
40 |
New |
$0.00 |
$6,035,000 |
1,350,000 |
0.5% |
6,035,000 |
1,350,000 |
0.962 |
N/A |
|
|
VYGR |
Voyager Therapeutics, Inc. |
42 |
New |
$8.23 |
$5,586,000 |
600,000 |
0.46% |
5,586,000 |
600,000 |
1.601 |
N/A |
|
|
BIO |
Bio Rad Laboratories Inc |
44 |
New |
$287.21 |
$5,188,000 |
15,000 |
0.43% |
5,188,000 |
15,000 |
0.061 |
Scientific & Technica... |
|
|
RARE |
Ultragenyx Pharmaceutical Inc |
45 |
New |
$40.34 |
$5,136,000 |
110,000 |
0.42% |
5,136,000 |
110,000 |
0.134 |
Restaurants |
|
|
ANRO |
Alto Neuroscience, Inc. |
48 |
New |
$12.92 |
$3,838,000 |
250,000 |
0.32% |
3,838,000 |
250,000 |
0.93 |
N/A |
|
|
LXEO |
Lexeo Therapeutics, Inc. |
49 |
New |
$0.00 |
$2,744,000 |
175,000 |
0.23% |
2,744,000 |
175,000 |
0 |
N/A |
|
|
NVAX |
Novavax Inc |
51 |
New |
$0.36 |
$2,390,000 |
500,000 |
0.2% |
2,390,000 |
500,000 |
0.421 |
Biotechnology |
|
|
ATRA |
Atara Biotherapeutics, Inc. |
53 |
New |
$0.62 |
$1,943,000 |
2,800,000 |
0.16% |
1,943,000 |
2,800,000 |
2.577 |
N/A |
|
|
LYEL |
Lyell Immunopharma, Inc. |
58 |
New |
$2.77 |
$290,000 |
130,000 |
0.02% |
290,000 |
130,000 |
0.054 |
N/A |
|
